Indeed, Naka and colleagues have shown that intra-tumoral delivery of SOCS1 by adenoviral vectors resulted in reduced PD-L1 expression that was correlated increased CD8+ T cell activation and improved tumor growth control (142). The gene discussed is SOCS1; the disease is neoplasm.